NCT04526795 2024-12-12Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory LeukemiaM.D. Anderson Cancer CenterPhase 1 Terminated19 enrolled
NCT00671112 2015-10-28Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaCase Comprehensive Cancer CenterPhase 1 Terminated30 enrolled